KLR Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$346K Buy
473
+3
+0.6% +$2.13K 0.25% 120
2023
Q4
$274K Buy
+470
New +$274K 0.2% 154
2023
Q3
Sell
-429
Closed -$201K 178
2023
Q2
$201K Buy
+429
New +$180K 0.17% 176

Other funds holding LLY

KLR Investment Advisors's LLY Position: Q1 2024 in Review

KLR Investment Advisors increased its Eli Lilly (LLY) stake by 0.64% in Q1 2024, buying an estimated $2.13K and bringing the position to 473 shares worth $346K. The position accounts for 0.25% of the portfolio, ranked #120.

KLR Investment Advisors first reported a position in LLY in Q2 2023 and has held it in 3 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • KLR Investment Advisors held 473 shares of Eli Lilly worth $346K as of Q1 2024.
  • KLR Investment Advisors bought 3 Eli Lilly shares in Q1 2024, an estimated $2.13K.
  • Eli Lilly made up 0.25% of KLR Investment Advisors's portfolio in Q1 2024, its #120 holding.
  • KLR Investment Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 3 quarters since.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.